NCT06748950View on ClinicalTrials.gov

Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
SchizophreniaSchizophrenia and Related DisordersBipolar DisorderBipolar and Related DisordersMajor Depressive DisorderMajor Depression SevereKetogenic DietingKetosisMetabolic DiseaseMetabolic Syndrome
Interventions
OTHER

LCHF Ketogenic Diet

Low Carbohydrate, Moderate Protein, High Fat (LCHF) Ketogenic Dietary Intervention for 12 weeks

OTHER

Diet-as-Usual (DAU)

Participant's usual diet

Trial Locations (1)

94304

Stanford University, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER